The Indian pharmaceutical sector is expected to grow five-fold in the next seven years to reach Rs. 5 lakh crore, as per government estimates.
“The department envisages that the industry will grow from its current level of Rs. 1 lakh crore to Rs. 5 lakh crore by 2020, becoming globally competitive and building India as a global provider of quality medicines at reasonable prices,” Department of Pharmaceuticals (DoP) Joint Secretary A J V Prasad said.
The pharmaceutical sector has grown over three-fold in the last 10 years to reach Rs. 1,19,075.7 crore. In 2000-01, the size of the sector stood at Rs. 33,0,11.8 crore.
“…the quick estimates for Gross Domestic product (GDP) for 2010-11 is Rs. 76,74,148 crore and the share of the pharma industry for 2010-11, which is based on CMIE data, is 1.55 per cent,” a source said.
The data for 2011-12 is not available, the official said, adding that the industry size in 1990-91 stood at Rs. 6,314.5 crore. For 2009-10, it was Rs. 1,06,209 crore.
In order to encourage production of drugs by indigenous industries, the 12th Five Year Plan (2012-17) has recommended capacity building of private sector to meet WHO-GMP standards and other international manufacturing standards.
The major recommendations of Plan include “enabling the Indian pharmaceutical industry to develop competence in advanced areas of drug manufacturing like dedicated research facility in bulk drugs, improving processes of manufacturing generics and APIs” the source said.
The Indian pharmaceutical industry is the third largest in terms of volume, and 13th in terms of value. The sector is growing at 14 per cent per annum.